Search Results
Oct 14, 2025, 12:43 ET Eightco Holdings Inc. ($ORBS) doet een strategische investering in Mythical Games om menselijke verificatie en digitale identiteit in games te versnellen
Mythical heeft al drie games live, met elk meer dan 1 miljoen installs: Pudgy Party (in samenwerking met Pudgy Penguins), NFL Rivals (in samenwerking met NFL en NFLPA) en FIFA Rivals (in samenwerking met FIFA en FIFPRO). Deze games hebben samen meer dan 10 miljoen installs
More news about: Eightco Holdings (NASDAQ: ORBS)
Oct 14, 2025, 12:00 ET COALITION FOR INNOVATION PUBLISHES BLUEPRINTS ON FUTURE VISION
The launch of the AI, CleanTech and HealthTech Blueprints underscores a fundamental belief that the greatest challenges of our time can be met with collective ingenuity. This initiative marks a pivotal starting point. The Coalition invites businesses, innovators, industry leaders, and organizations
More news about: LG Electronics USA
Oct 14, 2025, 11:02 ET Steward Partners Celebrates Advisors Recognized in InvestmentNews' Rising Stars List
background checks and interviews by Inc.'s research department, with a final vetting process by the editorial team to ensure ethical standards were met. As always, Inc. reserves the right to decline applicants for subjective reasons. Steward Partners nor its affiliates paid a fee to Inc. Magazine in
More news about: Steward Partners
Oct 14, 2025, 10:41 ET BitMine Immersion (BMNR) kondigt een ETH-bezit aan van meer dan 3,03 miljoen tokens en een totaal aan crypto- en geldmiddelen van $12,9 miljard
persbericht die niet louter historisch zijn, zijn toekomstgerichte verklaringen die risico's en onzekerheden met zich meebrengen. Dit document bevat specifiek toekomstgerichte verklaringen met betrekking tot de vooruitgang en verwezenlijking van de doelstellingen van het bedrijf inzake ETH-acquisitie
More news about: BitMine Immersion Technologies, Inc.
Oct 14, 2025, 09:32 ET iOnctura debuts cambritaxestat (IOA-289) clinical data in patients with pancreatic cancer at ESMO
neglected and hard-to-treat cancers, today announces the Phase Ib study investigating oral autotaxin (ATX) inhibitor, cambritaxestat (IOA-289), has met the primary endpoint: demonstrating safety, tolerability and anti-tumor responses, in combination with standard-of-care chemotherapy, in patients with
More news about: iOnctura
Oct 14, 2025, 09:03 ET Co-PSMA trial achieves primary endpoint
radical prostatectomy with no salvage therapy and a PSA level between 0.2 and 0.75 ng/mL. The Co-PSMA trial has successfully met its primary endpoint, demonstrating that 64Cu-SAR-bisPSMA PET/CT detects significantly more lesions per patient than the SOC, 68Ga-PSMA-11
More news about: Clarity Pharmaceuticals
Oct 14, 2025, 09:00 ET CurifyLabs Launches Next-Generation Compounding Software to Advance Personalized Medicine
Compounding—the preparation of customized medicines for patients whose needs cannot be met by mass-produced drugs—has long relied on manual, time-intensive processes with inherent risks. CurifyLabs is modernizing this essential practice with
More news about: CurifyLabs
Oct 14, 2025, 08:45 ET Atlanta Fibroid Center Celebrates 20 Years of Helping Over 10,000 Women Avoid Hysterectomy
an average age under 40. "My fibroid issues made me pay much closer attention to my body. I didn't know I had options until I met Dr. Lipman. With the UFE procedure, I was back to normal in about seven days," said Teresa Edwards, four-time Olympic gold medalist and 2011 inductee
More news about: Atlanta Fibroid Center
Oct 14, 2025, 08:36 ET Chimpanzee George Officially Finds Permanent Home at Chimpanzee Sanctuary Northwest
Northwest has been sharing George's journey through daily blog posts and social media updates, drawing support from people worldwide, including many who met George during his years at the roadside zoo. A recent video of George in the 2-acre outdoor habitat with another rescued chimpanzee, Terry, has inspired
More news about: Chimpanzee Sanctuary Northwest
Oct 14, 2025, 08:00 ET Daesang Successfully Participates in 'ANUGA 2025,' Secures Foothold for European Expansion
interest in Daesang's O'food and Jongga products. The company also engaged in in-depth discussions with local buyers to establish new supply contracts and met with many existing partners to expand its product lineup. Locally produced products such as Mat Kimchi, Gochujang, and Gochujang
More news about: Daesang Corporation
Oct 14, 2025, 07:56 ET AM General Announces Collaboration with Carnegie Robotics and Textron Systems to Develop Modular Unmanned Ground Vehicle for U.S. Army Modernization
President, Air, Land and Sea Systems at Textron Systems. "The M-MET is built to be modular, adaptable and future-ready, ensuring Soldiers have a scalable and versatile platform that meets the Army's evolving mission needs." The M-MET request for proposal is expected to be released in 2026.
More news about: AM General LLC
Oct 14, 2025, 07:00 ET Institutional Support for Shareholder Proposals Hits New Low, Broadridge ProxyPulse™ Report Finds
A decline in the number of proposals related to disclosure of political spending (from 46 in the 2024 proxy season to 18 this past season) was met with an increase in voting support. Retail support increased from 18% to 25% in favor and institutional support increased from 24% to 35%.
More news about: Broadridge Financial Solutions, Inc.
Oct 14, 2025, 06:00 ET Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
- Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a Phase III randomized, double-blind, placebo-controlled,
More news about: Ascletis Pharma Inc.
Oct 14, 2025, 05:35 ET Strategische Alliantie: TCL SunPower Global en VDH Solar bundelen krachten om zonne-energie toegankelijker te maken in Nederland
gesloten met VDH Solar, een van de meest vertrouwde groothandels in zonne-energie in Nederland. Via deze samenwerking biedt VDH Solar Nederlandse installateurs toegang tot de twee technologie-merken van TCL SunPower Global: TCL Solar en SunPower. Hiermee breidt VDH Solar zijn portfolio uit met een breder
More news about: TCL SunPower Global
Oct 14, 2025, 04:35 ET TCL SunPower Global breidt uit naar de Nederlandse markt met Natec als strategische distributiepartner
en ondersteunen we installateurs met de tools die ze nodig hebben om aan de groeiende vraag te voldoen." Natec ondersteunt professionele zonne-energiebedrijven in Nederland en staat bekend als de vertrouwde B2B groothandel voor slimme systemen met focus op partnerschap, kennis, technische
More news about: TCL SunPower Global
Oct 14, 2025, 03:30 ET First patient treated with Leqembi® (lecanemab) in the Nordics
countries, as well as the EC's market authorization, were primarily based on Phase 3 data from Eisai's global Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statistically significant results. Clarity AD was a Phase 3 global, placebo-controlled, double-blind,
More news about: BioArctic
Oct 14, 2025, 03:00 ET Hyland renforce sa présence dans le cloud européen et améliore l'accès des clients aux technologies d'IA avancées
Content Innovation Cloud™, annonce aujourd'hui l'expansion de sa présence en Europe, en collaboration avec Amazon Web Services (AWS). Hyland met ses solutions à disposition par l'intermédiaire de la région de Francfort d'AWS, offrant un accès à faible latence au Content Innovation Cloud dans toute
More news about: Hyland
Oct 14, 2025, 02:20 ET 華上生醫抗癌新藥GNTbm-TKI將在ESMO發表
是一種新型的多重激酶抑制劑，能顯著誘導腫瘤微環境（TME）中的免疫激活作用，顯示其在未滿足臨床需求的腫瘤免疫療法中具有潛在應用價值。 華上生醫在本次ESMO的研究發表顯示，GNTbm-TKI 主要是強效抑制 TYRO3、AXL、c-MER、BTK、ROS1、NTRK2、MET 和 VEGFR2 的活性，在nM濃度下具有非常強的抑制效果。GNTbm-TKI 在 NCI-60 人類癌症細胞系中表現出強大的抗增殖活性，GI50 值低。GNTbm-TKI 在 CT-26 模型中，和免疫缺陷小鼠相比，在野生型小鼠（免疫健全）中顯示出優異的體內抗癌療效，顯示GNTbm-TKI的優越抗癌活性與免疫活化有關。此外，GNTbm-TKI
More news about: 華上生醫
Oct 14, 2025, 02:19 ET Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-TKI, a Novel Multi-tyrosine Kinase Inhibitor with Potent Immune Activation, at the 2025 ESMO Annual Meeting
needs. The results of the study show that GNTbm-TKI strongly inhibited the activities of TYRO3, AXL, c-MER, BTK, ROS1, NTRK2, MET, and VEGFR2 at nanomolar level. GNTbm-TKI showed anti-proliferation activity in NCI-60 human cancer cell lines with low GI50 values. GNTbm-TKI
More news about: Great Novel Therapeutics Biotech & Medicals Corporation
Oct 14, 2025, 01:40 ET 2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China
[EULAR (European League Against Rheumatism) Sjögren's Syndrome Disease Activity Index] compared to placebo. Telitacicept met the primary endpoint and all key secondary endpoints. Patients in Telitacicept groups showed significant improvement in disease activity compared to
More news about: RemeGen Co., Ltd
Oct 13, 2025, 21:30 ET GIGABYTE annonce que son supercalculateur personnel AI TOP ATOM sera disponible dans le monde entier dès le 15 octobre
NVIDIA Grace Blackwell GB10, conçue pour le développement de l'IA sur site et qui met les performances d'un supercalculateur à la portée des ordinateurs de bureau. Avec la suite logicielle préinstallée
More news about: GIGABYTE
Oct 13, 2025, 19:30 ET LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
regions.LEQEMBI's approvals in these countries was based on Phase 3 data from Eisai's, global Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statistically significant results. The primary endpoint was the global cognitive and functional
More news about: Eisai Inc.
Oct 13, 2025, 16:30 ET FROM FRYING OIL TO COUPLING RELAYS: SIEMENS AND ENVALIOR COLLABORATE ON MORE SUSTAINABLE ELECTRICAL PRODUCTS
of industries by designing and developing high-quality sustainable solutions, in collaboration with Siemens to ensure all the desired properties are met. The plastic's raw material comes from used cooking oil (UCO), left over after frying in the food industry, restaurants, snack bars and households. As
More news about: Envalior B.V.
Oct 13, 2025, 16:30 ET FROM FRYING OIL TO COUPLING RELAYS: SIEMENS AND ENVALIOR COLLABORATE ON MORE SUSTAINABLE ELECTRICAL PRODUCTS
of industries by designing and developing high-quality sustainable solutions, in collaboration with Siemens to ensure all the desired properties are met. The plastic's raw material comes from used cooking oil (UCO), left over after frying in the food industry, restaurants, snack bars and households. As
More news about: Envalior B.V.
Oct 13, 2025, 16:27 ET EiIean Therapeutics Presents Novel Wild-Type Sparing, Reversible Pan-EGFR Inhibitor (ZE77-0273) with Broad Activity Against Resistance Mutations in EGFR-Mutant NSCLC at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
therapies. Eilean's oncology programs for therapy-resistant lung cancer include best-in-class reversible pan-EGFR inhibitor, c-Met inhibitor, and pan-KRAS molecular glue. For more information, visit
More news about: Eilean Therapeutics